Tor Biering-Sørensen, MD, MSc, MPH, PhD
@TorBiering
Followers
1K
Following
5K
Media
61
Statuses
1K
Professor and Head of Center for Translational Cardiology and Pragmatic Randomized Trials (@CTCPR_). Cardiac imaging, heart failure and RCT’s.
København, Danmark
Joined June 2020
In patients with CKD, SGLT2 inhibitors significantly reduced left ventricular mass compared to placebo. This was consistent across subgroups including baseline cardiovascular disease or etiology of kidney disease. Full DECODE-CKD trial results: https://t.co/UZvHJetjv0
2
7
21
Yet another one of @TorBiering’s discoveries - @LauraMariaAdam - just halfway through med school and already teaching us about the utility of lung ultrasound in acute heart failure at #AHA25! @CTCPR_ @fdavidovski_MD @Espersen_C
2
6
34
Thrilled to have presented not just one, but two late breaking featured science abstracts on FLUNITY-HD - and to have shared the stage with superstars like Daniel Modin, @ankeetbhatt, @SheilaHegde, @orlyvardeny - grateful to @TorBiering, @niklasdj1, @CTCPR_ for the opportunity!
1
5
19
Please find the most recent trial from the amazing @CTCPR_ team below 👇 , the NUDGE-FLU-CHRONIC 2 trial, brilliantly executed by the one and only @niklasdj1 👏
Original Article: “Digital Nudges to Increase Influenza Vaccination in Patients with Chronic Diseases” by N.D. Johansen et al. https://t.co/4XP0F77tA5
@TorBiering @CTCPR_ @AHAScience #AHA25
0
1
7
High-Dose vs. Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults: The FLUNITY-HD Prespecified Pooled Analysis | Circulation https://t.co/SAGbIrVvY6
@TorBiering #galflu #flunityHD #danflu2 @genvip @Xunta
ahajournals.org
Background: The high-dose inactivated influenza vaccine (HD-IIV) has demonstrated superior protection against a range of hospitalization endpoints versus standard-dose inactivated influenza vaccine...
0
3
2
We are hiring yet a again👇 This time we are looking for a skilled biostatistician. Come join the most innovative and creative team, and help us in redefining how we should conduct randomized controlled trials in a more efficient and inclusive way.
Join @CTCPR_! Are you a Data Manager or Biostatistician passionate about cardiovascular research? Join us to support innovative clinical trials and register-based studies, turning complex datasets into insights that can shape future treatments. Be part of a dynamic and growing
0
2
4
We are hiring yet again👇 This time we are looking for skilled medical doctors, interested in clinical research. Come join the most innovative and creative team, and help us in redefining how we should conduct randomized controlled trials in a more efficient and inclusive way.
🚨 News from @CTCPR_: We are looking for a PhD Fellow to join our team and support ongoing research projects. Help us advance cardiology research and contribute to meaningful studies. 🔗 Apply here: https://t.co/Wcp0CHbku4
@TorBiering
@Stenodiabetes
@CopCard
@Rigshospitalet
0
2
3
New study from @FudimMarat's team from @DCRINews with @TorBiering from @CTCPR_ , published in the European Journal of Heart Failure, shows that patients with biopsy-proven MASLD face a significant risk of heart failure (HF). Over 11 years, nearly 18% developed HF, and almost 50%
0
3
5
The main results of our NUDGE-FLU-CHRONIC 2 trial simultaneously published with the LBCT presentation at #AHA. We found that the most effective nudge strategy to increase flu vaccine uptake was using repeated cardiovascular-focused nudges. 👏 @niklasdj1 @CTCPR_
Flu causes major illness and death yearly, but vaccination rates are falling. In a Danish RCT, electronic nudges significantly increased vaccination rates, with the largest effect size using repeated cardiovascular-focused nudges. https://t.co/4XP0F77tA5
@AHAScience | #AHA25
0
1
3
Our most recent publication from FLUNITY-HD published simultaneously with the LBCT presentation by @MananPareekMD. We find that HD flu vaccines are associated with significantly lower risk of cardiovascular and respiratory hospitalizations than SD flu vaccines. @CTCPR_ @niklasdj1
#AHA25 The high-dose influenza vaccine appears to provide broader protection against severe cardio-respiratory events than standard-dose vaccine in older adults including those with established cardiovascular disease https://t.co/kYjd5tOcAt
@niklasdj1 @KiraJanstrup @TorBiering
0
2
2
🚨 Could zoster vaccination protect your heart? – @CTCPR_ 🫀🧬 In a new @ESC_Journals editorial, @PedersenTorp & @TorBiering discuss South Korean data suggesting that live herpes zoster vaccination may lower cardiovascular risk. 💡 Vaccinated individuals had 95 more days free
0
1
6
We are hiring 👇 Come join the most innovative and creative team, and help us in redefining how we should conduct randomized controlled trials in a more efficient and inclusive way.
Exciting Opportunity at @CTCPR_ ! We are looking for a Project Nurse with cardiology experience to help coordinate and conduct innovative national and international cardiovascular clinical trials. Join us and be part of cutting-edge cardiology research! https://t.co/W7ncMA1Yoz
0
1
2
Exciting Opportunity at @CTCPR_ ! We are looking for a Project Nurse with cardiology experience to help coordinate and conduct innovative national and international cardiovascular clinical trials. Join us and be part of cutting-edge cardiology research! https://t.co/W7ncMA1Yoz
0
1
2
💙 SGLT2 inhibitors reshape the heart in CKD DECODE-CKD trial (n=222), dapagliflozin significantly reduced left ventricular mass index 🫀 vs placebo after 6 months ✨ Mechanistic insight: Dapa may reverse adverse cardiac remodelling, explaining its early cardiorenal benefits.
1
28
88
Cardiac Effects of Dapagliflozin in People with Chronic Kidney Disease In a heterogeneous population of patients with chronic kidney disease, dapagliflozin significantly reduced left ventricular mass index compared with placebo. These findings provide mechanistic insights into
1
6
18
High versus standard-dose influenza vaccine in patients with and without atherosclerotic cardiovascular disease: no significant difference in major CV events but hints of fewer cardiorespiratory hospitalizations. Read the result of DANFLU-2 trial in #EHJ. https://t.co/AJgp9NaSal
2
8
22
Several important implications of assessing comprehensive #CkmGDMT in clinical trials & clinical care #ScoreCKM 🎯 Pre-trial planning/event rate estimates 🎯 Medical therapy drop in 🎯 HTE by background therapy 🎯 Primary Endpt in #ImpSci trials 🎯 Guiding #PopHealth initiatives
0
2
6